Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Advances in Medical Sciences
- Vol. 63 (1) , 160-166
Abstract
No abstract availableKeywords
Funding Information
- National Science Centre, Poland (2013/09/D/NZ5/00252)
- Department of Scientific Research and Structural Funds of Medical College, Jagiellonian University (K/ZDS/004596)
This publication has 33 references indexed in Scilit:
- Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure, 2011
- Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart FailureJACC, 2011
- Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart FailureCirculation: Heart Failure, 2008
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Propeptide of procollagen type I (PIP) and outcomes in decompensated heart failureEuropean Journal of Internal Medicine, 2007
- O papel do acúmulo de colágeno no interstício miocárdico na sobrevida dos pacientes com cardiomiopatia dilatada idiopática e chagásicaArquivos Brasileiros de Cardiologia, 2006
- Myocardial proteases and matrix remodeling in inflammatory heart diseaseCardiovascular Research, 2006
- Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human HeartCirculation, 2003
- Patterns of myocardial fibrosis*1Journal of Molecular and Cellular Cardiology, 1989
- Dilated (congestive) cardiomyopathy: a syndrome of severe cardiac dysfunction with remarkably few morphological features of myocardial damageHistopathology, 1985